Treatment Options for NMOSD in Children: Effectiveness and Safety of Subcutaneous Tocilizumab (P12-8.009)

Authors

Amanda Frisosky Abuaf
Alejandra Duque Ramirez
Laura Dresser
Adil Javed (ORCID: https://orcid.org/0000-0002-1834-7606)

Institutions

University of Chicago (US)

Publication Details

Journal: Neurology
Published: 2025-04-07
DOI: https://doi.org/10.1212/wnl.0000000000212294
Citations: 2
Primary Topic: Hereditary Neurological Disorders
Type: article
Field-Weighted Citation Impact: 1.82

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Treatment Options for NMOSD in Children: Effectiveness and Safety of Subcutaneous Tocilizumab (P12-8.009)

Amanda Frisosky Abuaf, Alejandra Duque Ramirez, Laura Dresser, Adil Javed

Apr 7, 2025

2 citations

Neurology

Hereditary Neurological Disorders

1.82

article

Treatment Options for NMOSD in Children: Effectiveness and Safety of Subcutaneous Tocilizumab (P12-8.009)

Amanda Frisosky Abuaf, Alejandra Duque Ramirez, Laura Dresser, Adil Javed

April 7, 2025article en

2 citations

Abstract

No abstract available for this paper.

NeurologyVol. 104(7_Supplement_1)

University of Chicago (US)

Openalex Percentile: Top 17%

Hereditary Neurological Disorders

1.82

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Treatment Options for NMOSD in Children: Effectiveness and Safety of Subcutaneous Tocilizumab (P12-8.009) — Amanda Frisosky Abuaf, Alejandra Duque Ramirez, et al. · Neurology (2025) | TGRS Research Map | TGRS